---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-063287"
form_type: "8-K"
ticker: "UTHR"
cik: "0001082554"
company_name: "UNITED THERAPEUTICS Corp"
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:36:07.938735+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve amended 2015 Stock Incentive Plan; increase share reserve by 950k shares and extend plan to 2035

## Summary
- Shareholders approved amendment to 2015 Stock Incentive Plan, increasing share reserve by 950,000 shares to 14,770,000 total.
- Plan expiration extended to April 24, 2035; Lead Independent Director retainer increased by $5,000 per year.
- All 12 director nominees elected; say-on-pay passed with ~95% of votes cast.
- The stock plan amendment passed with ~92% of votes cast; Ernst & Young ratified as auditor.

## SEC filing metadata
- accession: 0001104659-25-063287
- form_type: 8-K
- ticker: UTHR
- cik: 0001082554
- company_name: UNITED THERAPEUTICS Corp
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082554/000110465925063287/0001104659-25-063287-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082554/000110465925063287/tm2519194d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-063287
- JSON: https://secwatch.observer/filing/0001104659-25-063287.json
- Plain text: https://secwatch.observer/filing/0001104659-25-063287.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.